Open access
Population‐level diagnostic and radiation treatment trends of low‐risk prostate cancer
S. Monda
Varshini S. Odayar
Maggie Yin
Rachel T. Gonzalez
S. Jaime-Casas
K. Hopfensperger
D. Kendrick
M. Mietzel
M. Mislmani
M. Zaki
P. W. McLaughlin
Todd M. Morgan
W. Jackson
M. Schipper
D. Heimburger
Alex K. Bryant
L. Pierce
T. Borza
R. Dess
Medicine
Abstract
Overtreatment of low‐risk prostate cancer (PC) undermines screening efforts. Active surveillance is preferred for low‐risk PC, but declining treatment may reflect diagnostic or treatment‐selection changes. We assessed diagnostic risk‐group trends among localized PC and low‐risk trends among radiation‐treated patients since 2010.